Anaphalis nubigena DC. var. monocephala (DC.) C. B. Clarke (Asteraceae) is widely distributed in temperate regions from Kashmir to Sikkim and Afghanistan to South West China at a height of 2200-4000 m [1] . The fresh leaves of Anaphalis species are bruised and applied to cut wounds under a cloth bandage [2] . When taken before meals, the leaves are known to stimulate the appetite and, as a result, they are administered to convalescents for their tonic properties [3] . Previous investigations of the essential oil of different species of Anaphalis have reported a variety of compounds. A. margaritacea, a Chinese medicinal herb, showed the presence of γ-sitosterol, nonacosane, α-cadinol [4] , rosefuran and rosefuran epoxide [5] . The oil from the leaves of A. contorta was reported to possess α-thujene, α-thujone, linalyl acetate, nerol, linalool, p-cymen [3] , 1,8 cineole, α-d-phellandrene, d-limonene, dipentene and fenchone [6] . However, in another study of the essential oil from the aerial parts of A. contorta, caryophyllene oxide, α-cadinol, caryophyllene alcohol, γ-muurolene, 14-hydroxy-9-epi-β-caryophyllene, ar-curcumene and β-bisabolene were the major constituents [7] . The oil from the leaves of A. contorta showed inhibitory activity against human pathogenic bacteria and fungi [8] . An extract of A. triplinervis was showed to possess diuretic properties [9] , while antibacterial activity has been reported for A. cuneifolia [10] . However, no activity was reported for the extract of A. cinnamomea [11] . In this paper we report the chemical composition and antimicrobial activity of the essential oil of A. nubigena, which has not been reported previously to our knowledge.
The results of GC and GC/MS analysis of the oil from the aerial parts of A. nubigena are given in Table1. Sixty compounds were identified, which represented 95.9% of the total oil. The major constituents were α-guaiene (12.3%), γ-muurolene (10.4%), γ-cadinene (8.3%), α-muurolol (7.4%), α-gurjunene (6.0%) and α-bulnesene (5.8%). The oil was rich in sesquiterpene hydrocarbons (60.1%), followed by oxygenated sesquiterpenes (24.5%), diterpenes (8.2%), monoterpene hydrocarbons (2.1%), oxygenated monoterpenes (0.5%) and long chain hydrocarbons (0.5%).
In vitro antimicrobial activity of the essential oil is shown in 
Isolation of essential oil:
The plant material (1 kg) was steam distilled for 3 h using a copper still fitted with spiral glass condensers and extracted with n-hexane and dichloromethane. The organic phase was dried over anhydrous sodium sulfate and the solvent recovered using a thin film rotary vacuum evaporator at 
Antimicrobial activity:
The in vitro antimicrobial activity was evaluated by the disc diffusion method using nutrient agar for bacterial strains and potato dextrose agar for fungal strains [13] . The essential oil was dissolved in 10% aqueous dimethylsulfoxide (DMSO) [14] ) with Tween 80 (1.0% v/v for easy diffusion). Under aseptic conditions, empty sterilized discs (HIMEDIA SD 067, 6 mm diameter) were impregnated with 20 μL of different concentrations (4000 µg/mL-3.9 µg/mL) of the essential oil and placed on the agar surface [15] . Negative controls were prepared using discs impregnated with 10% aqueous DMSO with 1.0% Tween 80 (solvent control) and virgin discs (blank control). The inhibition zones were measured in mm after 24 h and 48 h of incubation at 37 o C for bacteria and fungi, respectively. Gentamicin and fluconazole were used as positive controls for bacteria and fungi, respectively ( Table 2 ).
The minimum inhibitory concentration (MIC) was determined by the tube-dilution method using sterile peptone water. Essential oil was dissolved in 10% aqueous DMSO with Tween 80 (1.0%) to a concentration range between 4000 µg/mL and 3.9 µg/mL. One mL of each concentration of oil was mixed with 1.0 mL of peptone water (10 4 CFU/mL for bacterial and 10 3 CFU/mL for fungal concentration, obtained from a McFarland turbidity standard no. 0.5) and incubated for 24 h and 48 h at 37 o C for bacteria and fungi, respectively. MIC was defined as the lowest concentration that inhibits visible bacterial growth [16, 17] (Table 2) .
